TC Biopharm (Holdings) Plc (ADR)
General ticker "TCBP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $454.6M (TTM average)
TC Biopharm (Holdings) Plc (ADR) does not follow the US Stock Market performance with the rate: -38.4%.
Estimated limits based on current volatility of 9.6%: low 0.24$, high 0.45$
Factors to consider:
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [70.18$, 362.90$]
- 2024-12-30 to 2025-12-30 estimated range: [20.08$, 108.48$]
Short-term TCBP quotes
Long-term TCBP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 |
|---|---|---|
| Operating Revenue | £3.84MM | £0.00MM |
| Operating Expenses | £15.93MM | £14.24MM |
| Operating Income | £-12.08MM | £-14.24MM |
| Non-Operating Income | £9.05MM | £7.24MM |
| Interest Expense | £6.75MM | £0.08MM |
| R&D Expense | £7.59MM | £7.77MM |
| Income(Loss) | £-3.03MM | £-7.00MM |
| Taxes | £-1.72MM | £-1.09MM |
| Profit(Loss)* | £-1.31MM | £-5.91MM |
| Stockholders Equity | £0.33MM | £2.69MM |
| Assets | £11.29MM | £8.93MM |
| Operating Cash Flow | £-15.29MM | £-10.54MM |
| Capital expenditure | £0.24MM | £0.11MM |
| Investing Cash Flow | £-0.31MM | £-0.21MM |
| Financing Cash Flow | £18.65MM | £8.52MM |
| Earnings Per Share** | £-11.90 | £-5.95 |
| Ordinary share to ADR | 0.01x | 0.01x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.